ancer C Diagnosis of Colorectal Innovation Workshop in Prevention Early Detection & June 2014 5 th 6 th Heidelberg INNOVATION IN PREVENTION, EARLY DETECTION & DIAGNOSIS OF COLORECTAL CANCER Heidelberg – Germany June 5 TH – 6 TH 2014 UniversitätsKlinikum Heidelberg
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
ancerCDiagnosis ofColorectal
Innovation
Wor
ksho
p
in PreventionEarly Detection &
June 20145th
6th
Hei
del
ber
g
INN
OVA
TIO
N IN
PR
EVEN
TIO
N, E
AR
LY D
ETEC
TIO
N &
DIA
GN
OSI
S O
F C
OLO
REC
TAL
CA
NC
ER
Hei
del
ber
g –
Ger
man
y Ju
ne 5
TH –
6TH
201
4
UniversitätsKlinikum Heidelberg
June 5th 2014
12:00 – 12:30 Harald zur Hausen German Cancer Research Center, HeidelbergKey Note Speech: Links of Colorectal Cancer to Infections
Session I Innovative Approaches in Colorectal Cancer Early DetectionChair: Hermann Brenner
12:30 – 12:50 Frank KolligsLudwig Maximilian University, MunichTitle – to be announced
12:50 – 13:10 John E. BlumeApplied Proteomics Inc., San Diego Title – to be announced
13:10 – 13:30 Markus F. NeurathUniversity Medical Center, ErlangenTitle – to be announced
13:30 – 13:50 Hans Jørgen NielsenUniversity of Copenhagen Title – to be announced
13:50 – 14:10 Friedrich-Wilhelm TillerFred Hutchinson Cancer Research Center, SeattleProbing of Tandem-Mass-Spectrometry as a Non-Immunochemical Reference Method for Hb Quantification in Feces
14:10 – 14:30 Polly A. NewcombFred Hutchinson Cancer Research Center, SeattleTitle – to be announced
14:30 – 14:50 Hermann BrennerGerman Cancer Research Center, HeidelbergInnovative Epidemiology for Colorectal Cancer Early Detection
14:50 – 15:10 Coffee Break
Session IIAspirin in Colon Cancer PreventionChair: Cornelia Ulrich & Jürgen Riemann
15:10 – 15:30 John BaronDartmouth Cancer Center Vitamin D and Aspirin in Cancer Prevention – The Evidence Today
15:30 – 15:50 Nadir ArberManor Medical Center, Tel Aviv Aspirin and Familiar Predisposition to Colorectal Cancer
15:50 – 16:10 Gabriela MösleinHELIOS St. Josef Hospital, Bochum-LindenThe German Status of Moving Anti-Inflammatory Drugs Into The Clinic for High-Risk Individuals
16:10 – 16:30 Cornelia UlrichNational Center for Tumor Diseases, HeidelbergPharmacogenetics of Aspirin and Anti-Inflammatory Agents: Moving Towards Translation Through Personalized Prevention Strategie
16:30 – 16:50 Coffee Break
Session III Immunotherapy in Colorectal CancerChair: Dirk Jäger
16:50 – 17:10 Nils HalamaNational Center for Tumor Diseases, HeidelbergTitle – to be announced
17:10 – 17:30 Ugur SahinTranslational Oncology (TRON), MainzTitle – to be announced
17:30 – 17:50 Philipp BeckhoveGerman Cancer Research Center, Heidelberg Title – to be announced
17:50 – 18:10 Hans-Georg RammenseeUniversity Medical Center, TübingenTitle – to be announced
18:10 – 18:30 Magnus von Knebel-DoeberitzUniversity Hospital, HeidelbergThe Immune Biology of DNA Mismatch Repair Deficient Tumor Cells: Towards a Vaccine for Hereditary Colon Cancer
18:30 Welcome Reception at DKFZ
June 6th 2014
Session IVGenomics, Epigentics and Risk Stratification of Colorectal Cancer Chair: Hanno Glimm
9:00 – 9:20 Jane FigueiredoUniversity of Southern California, Los AngelesTitle – to be announced
9:20 – 9:40 Davina GaleCancer Research UK Cambridge InstituteTitle - to be announced
9:40 – 10:00 Wilko Weichert University Hospital, HeidelbergTitle – to be announced
10:00 – 10:20 Joachim P. SpatzMax Planck Instiute for Metals Research, Los AngelesTitle – to be announced
10:20 – 10:40 Coffee Break
Session VColon MicrobiomeChair: Dirk Haller
10:40 – 11:00 Meredith HullarFred Hutchinson Cancer Research Center, SeattleTitle – to be announced
11:00 – 11:20 Mathias Chamaillard Centre d’Infection et d’Immunité de LilleTitle – to be announced
11:20 – 11:40 Peer BorkEuropean Molecular Biology Laboratory, HeidelbergTitle – to be announced
11:40 – 12:00 Stephen J. O’KeefeSmall Intestinal Rehabilitation & Transplant Center and Clinical Nutrition Service, University of PittsburghTitle – to be announced
12:00 – 12:20 Jiyoung AhnMedical Center, University of New YorkTitle – to be announced
12:20 – 12:40 Christian JobinCollege of Medicine, University of Florida Title – to be announced
12:40 – 13:30 Lunch Break
Session VIOncology PipelineChair: Christof von Kalle
13:30 – 15:30 Presentation of New Developments of Pharmaceutical Industry
Session VIIPanel Discussion
15:30 – 16:30 Moderation: Jörg Rüdiger SiewertMedical Director & President of the University Hospital Executive Board of Directors of the University Hospital of Freiburg
Participants of the Panel Discussion:
Friedrich von Bohlen, dievini Hopp BioTech holding GmbH & Co. KG and Chairman of the Board of Directors, Molecular Health AGWerner Eberhardt,Chief Health Platform Expert, SAP AGMichael HallekHaed of Hospital I for Internal Medicine, University of Cologne Otmar D. WiestlerChairman & Scientific Director of German Cancer Research Center, Heidelberg
UniversitätsKlinikum Heidelberg
June 5th 2014 June 6th 2014
INN
OVA
TIO
N IN
PR
EVEN
TIO
N, E
AR
LY D
ETEC
TIO
N &
DIA
GN
OSI
S O
F C
OLO
REC
TAL
CA
NC
ER
Hei
del
ber
g –
Ger
man
y Ju
ne 5
TH –
6TH
201
4
Location:
German Cancer Research Center (DKFZ)Communication Center, Lecture HallIm Neuenheimer Feld 280, 69120 Heidelberg
Site Map:
Information and Registration:
Viktoria ReinhardtPhone: +49 (0) 6221 56-350 99 Fax: +49 (0) 6221 56-5094E-mail: [email protected]
Please register by email: [email protected]
Hosted by the National Center for Tumor Diseases (NCT) Hei-delberg, the German Cancer Research Center, the Felix Burda Foundation and the German Network Against Colorectal Cancer the 2014 Workshop on Innovation in Prevention, Early Detection and Diagnosis of Colorectal Cancer will bring together academics, scientists, clinicians and leaders of the pharmaceutical industry to share innovations and to discuss and foster new developments in prevention and early detection strategies for colorectal cancer.
Colorectal cancer is not only a major public health burden, but is also effectively preventable. The interdisciplinary work-shop will cover state of the art research in colorectal cancer screening and early detection, prevention strategies by anti- inflammatory drugs, genomics, immunology, and gut micro-biomics. For a joint approach and optimal exchange of information, the workshop will provide the maximum amount of interaction and discussion through an exciting range of presentations.
We hope that you will join us on June 5th–6th 2014 at our Innovation Workshop in the beautiful city of Heidelberg and strengthen our links in colorectal cancer research.
Best Regards,
Christof von KalleDirector, Translational Oncology
National Center for Tumor Diseases Heidelberg
Otmar D. WiestlerChairman and Scientific DirectorGerman Cancer Research Center
Dirk JägerDirector, Medical Oncology
National Center for Tumor Diseases Heidelberg
Georg Ralle Secretary General of German Network
Against Colorectal Cancer
Cornelia UlrichDirector, Preventive Oncology
National Center for Tumor Diseases Heidelberg
Christa MaarCEO Felix Burda FoundationPresident of German Network
Against Colorectal Cancer
ancerCDiagnosis ofColorectal
Innovation
Wor
ksho
p
in PreventionEarly Detection &
June 20145th
6th
Hei
del
ber
g
Related Documents
